Form 4: Centene Director Kenneth Burdick Reports Acquisition of Restricted Stock Units

Director Kenneth Burdick reports acquisition of 2,916 restricted stock units in Centene Corp.

Summary

• Kenneth A. Burdick, a director of Centene Corp, reported a transaction on May 14, 2024.
• Burdick acquired 2,916 shares of common stock through restricted stock units.
• These restricted stock units will vest in full on the earlier of May 14, 2025, or the date of Centene's next annual meeting of stockholders.
• Following the transaction, Burdick directly owns 361,066.924 shares of common stock.
• Burdick also indirectly owns 86,498 shares through the Burdick Family LLC, of which he is a chief manager, but disclaims beneficial ownership except to the extent of his pecuniary interest.
• Burdick also owns 10,000 common stock options exercisable from February 7, 2025, expiring on February 7, 2032, with an exercise price of $80.57.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The acquisition of stock units by a director is generally viewed positively, but it's not a major event.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is tied to the director's continued service or the occurrence of the next annual meeting, aligning his interests with those of the shareholders.

Management Comments

• Mr. Burdick disclaims beneficial ownership of the securities held by the Burdick Family LLC except to the extent of his pecuniary interest therein.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track the buying and selling activities of directors and officers.

Comparison to Industry Standards

• Comparing Burdick's holdings and transactions to those of other directors in similar healthcare companies (e.g., UnitedHealth Group, Anthem) would provide context on the scale of his investment and alignment with company performance.
• Benchmarking the vesting schedule of the restricted stock units against industry norms for executive compensation packages would also be relevant.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's holdings and alignment with company performance.

Key Dates